Effects of fibrinolytic inhibitors on chondrogenesis of bone-marrow derived mesenchymal stem cells in fibrin gels

Biomechanics and Modeling in Mechanobiology

Volumn 6, Issue 1-2, 2007, Pages 5-11

  Huang, C Y C ^a   Cheung, H S ^a,b   Deitzer, M A ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b University of Miami College of Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; DNA; GELS; GENES; PROTEINS;

AMINOHEXANOIC ACID; BONE MARROW; CHONDROGENESIS; FIBRIN GELS;

CELLS;

ORYCTOLAGUS CUNICULUS;

AGGRECAN; AMINOCAPROIC ACID DERIVATIVE; ANTIFIBRINOLYTIC AGENT; APROTININ; COLLAGEN TYPE 2; FIBRIN; GLYCOSAMINOGLYCAN; MESSENGER RNA; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE MARROW CELL; CHONDROGENESIS; CYTOLOGY; DRUG EFFECT; GEL; GENE EXPRESSION REGULATION; GENETICS; MESENCHYMAL STEM CELL; METABOLISM; RABBIT;

AGGRECANS; AMINOCAPROIC ACIDS; ANIMALS; ANTIFIBRINOLYTIC AGENTS; APROTININ; BONE MARROW CELLS; CHONDROGENESIS; COLLAGEN TYPE II; FIBRIN; GELS; GENE EXPRESSION REGULATION; GLYCOSAMINOGLYCANS; MESENCHYMAL STEM CELLS; PROTEOGLYCANS; RABBITS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 33845406244     PISSN: 16177959     EISSN: 16822978     Source Type: Journal    
DOI: 10.1007/s10237-006-0033-2     Document Type: Article

References (39)

1. Barrons RW, Jahr JS (1996) A review of post-cardiopulmonary bypass bleeding, aminocaproic acid, tranexamic acid, and aprotinin. Am J Ther 3:821-838
2. Bensaid W, Triffit JT, Blanchat C, Oudina K, Sedel L, Petite H (2003) A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. Biomaterials 24:2497-2502
3. Bradfield JF, Bode AP (2003) Aprotinin restores the adhesive capacity of dysfunctional platelets. Thromb Res 109:181-188
4. Caterson EJ, Nesti LJ. Li WJ, Danielson KG, Albert TJ, Vaccaro AR, Tuan RS (2001) Three-dimensional cartilage formation by bone-marrow derived cells seeded in polyactide/alginate amalgam. J Biomed Mater Res 57:394-403
5. Cheung HS, Cottrell WH, Stephenson K, Nimni ME (1978) In vitro collagen biosynthesis in healing and normal rabbit articular cartilage. J Bone Joint Surg Am 60:1076-1081
6. Donahue MA, Price PM (2002) Aprotinin: antifibrinolytic and anit-inflammatory mechanisms of action in cardiac surgery with cardiopulmonary bypass. Dynamics 13:16-23
7. Farndale RW, Buttle DJ, Barrett AJ (1986) Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883:173-177
8. Fortier LA, Nixon AJ, Mohammed HO, Lust G (1997) Altered biological activity of equine chondrocytes cultured in a three-dimensional fibrin matrix and supplemented with transforming growth factor beta-1. Am J Vet Res 58:66-70
9. Fortier LA, Brofman PJ, Nixon AJ, Mohammed HO (1998) Disparate chondrocyte metabolism in three-dimensional fibrin cultures derived from autogenous or commercially manufactured fibrinogen. Am J Vet Res 59:514-520
10. Fortier LA, Mohammed HO, Lust G, Nixon AJ (2002) Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84:276-288
11. Fussenegger M, Meinhart J, Hobling W, Kullich W, Funk S, Bernatzky G (2003) Stabilized autologous fibrin-chondrocyte constructs for cartilage repair in vivo. Ann Plast Surg 2003 51:493-498
12. Greilich PE, Okada K, Latham P, Kumar RR, Jessen ME (2001) Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid. Circulation 104(suppl 1):I265-I269
13. Hendrickson DA, Nixon AJ, Grande DA, Todhunter RJ, Minor RM, Erb H, Lust G (1994) Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res 12:485-497
14. Herbert JM, Carmeliet P (1997) Involvement of u-PA in the anti-apoptotic activity of TGF-β for vascular smooth muscle cells. FEBS Lett 413:401-404
15. Hill GE, Taylor JA, Robbins RA (1997) Differing effects of aprotinin and epsilon-aminocaproic acid on cytokine-induced inducible nitric oxide synthase expression. Ann Thorac Surg 63:74-77
16. Huang CY, Reuben PM, D'lppolito G, Schiller PC, Cheung HS (2004a) Chondrogenesis of human bone marrow-derived mesenchymal stem cells in agarose culture. Anat Rec A Discov Mol Cell Evol Biol 278:428-36
17. Huang C-Y, Hagar KL, Frost LE, Sun Y, Cheung HS (2004b) Effects of cyclic compressive loading on chondrogenesis of rabbit bone-marrow derived mesenchymal stem cells. Stem Cells 22:313-323
18. Johnson LL (1986) Arthroscopic abrasion arthroplasty historical and pathologic perspective: present status. Arthroscopy 2:54-69
19. Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU (1998) In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res 238:265-272
20. Kim Y-J, Sah RLY, Doong J-YH. Grodzinsky AJ (1988) Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174:168-176
21. Lijnen HR (2002) Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc) 67:92-98.
22. Longstaff C (1994) Studies on the mechanisms of action of aprotinin and tranexamic acid as plasmin inhibitors and antifibrinolytic agents. Blood Coagul Fibrinol 5:537-542
23. Mackay AM, Beck SC, Murphy JM, Barry FP, Chichester CO, Pittenger MF (1998) Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow. Tissue Eng 4:415-428
24. Meinhart J, Fussenegger M, Hobling W (1999) Stabilization of fibrinchondrocyte constructs for cartilage reconstruction. Ann Plast Surg 42:673-678
25. Nixon AJ, Fortier LA, Williams J, Mohammed H (1999) Enhanced repair of extensive articular defects by insulin-like growth factor-I-laden fibrin composites. J Orthop Res 17:475-487
26. Passaretti D, Silverman RP, Huang W, Kirchhoff CH, Ashiku S, Randolph MA, Yaremshuk MJ (2001) Cultured chondrocytes produce injectable tissue engineered cartilage in hydrogel polymer. Tissue Eng 7:805-815
27. Pedrozo HA, Schwartz Z, Robinson M, Gomez R, Dean DD, Bonewald LF, Boyan BD (1999) Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-β 1 form the extracellular matrix of growth plate chondrocytes. Endo 140:5806-5816
28. Pittenger MF, Mackay AM, Bech SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshcak DR (2004) Multilineage of adult human mesenchymal stem cells. Science 284:143-147
29. Ray MJ, Hales M, Marsh N (2001) Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass. Blood Coagul Fibrinolysis 12:129-135
30. Shapiro F, Koide S, Glimcher MJ (1993) Cell origin and differentiation in the repair of full thickness defects of articular cartilage. J Bone Joint Surg Am 75:532-553
31. Silverman RP, Passaretti D, Huang W, Randolph MA, Yaremchuk MJ (1999) Injectable tissue-engineered cartilage using a fibrin glue polymer. Plast Reconstr Surg 103:1809-1818
32. Sims CD, Butler PE, Cao YL, Casanova R, Randolph MA, Black A, Vacanti CA, Yaremchuk MJ (1998) Tissue engineered neocartilage using plasma derived polymer substrates and chondrocytes. Plast Reconstr Surg 101:1580-1585
33. Solchaga LA, Johnstone B, Yoo JU, Goldberg VM. Caplan AI (1999) High variability in rabbit bone marrow-derived mesenchymal cell preparations. Cell Transplant 8:511-519
34. Swartz MF, Fink GW, Searles B (2004) Aprotinin and hemostatisis monitoring concerns during cardiac surgery. J Extra Corpor Technol 36:375-338
35. Wakitani S, Imoto K, Yamamoto T, Saito M, Murata N, Yoneda M (2002) Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Oseoarthr Cart 10:199-206
36. Westreich R, Kaufman M, Gannon P, Lawson W (2004) Validating the subcutaneous model of injectable autologous cartilage using a fibrin glue scaffold. Laryngoscope 114:2154-2160
37. Worster AA, Brower-Toland BD, Fortier LA, Bent SJ, Williams J, Nixon AJ (2001) Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor-betal in monolayer and insulin-like growth factor-I in a three-dimensional matrix. J Orthop Res 19:738-749
38. Xu JW, Zaporojan V, Peretti GM, Roses RE, Morse KB, Roy AK, Mesa JM, Randolph MA, Bonassar LJ, Yaremchuk MJ (2004) Injectable tissue-engineered cartilage with different chondrocyte sources. Plast Reconstr Surg 113:1361-1371
39. Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B (1998) The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J Bone Joint Surg Am 80:1745-1757